Harold A Deas, Jr.
Chief Executive Officer
In his role as Chief Executive Officer, Deas is responsible for providing the day-to-day leadership decisions and for implementing Acella’s short and long term strategic goals. Deas previously held the position of Chief Operating Officer for Acella. Prior to Acella, Mr. Deas was Vice President, Sales and Marketing for Alliant Pharmaceuticals, and was an integral component in the company’s overall success. Prior to Alliant, Deas served as Regional Sales Manager for Genentech Pharmaceuticals.
The significant contributions Deas has made throughout his career within the pharmaceutical industry provides the necessary framework for future growth and sustainability.
Senior VP, Clinical and Regulatory Affairs
Head of Research & Development
As Vice President, Head of R&D. Fields is responsible for research and development, product development, clinical affairs, regulatory and technical affairs, quality and training.
Fields has more than 20 years of experience as a clinical and regulatory-affairs professional. He has managed IDEs, INDs, MAAs, NDAs, ANDAs, SNDAs, 510Ks, and PMAs, preparation, strategic clinical and regulatory planning, meetings with the global regulatory agencies, and drug development. He has held senior clinical and regulatory affairs positions at small and large pharmaceutical firms, and has been an independent consultant and a Director at Quintiles International.
Fields holds a B.S. in Chemistry from Kansas Wesleyan University; M.Ed. and M.S. work at Kansas State University; graduate work at University of Kansas School of Medicine; Neuropharmacology Fellowship at Duke University; and currently additional graduate work at Johns Hopkins University.
Please fill out the form below.